Literature DB >> 28823572

A study of appendiceal crypt cell adenocarcinoma (so-called goblet cell carcinoid and its related adenocarcinoma).

Daisuke Nonaka1, George Papaxoinis2, Angela Lamarca2, Paul Fulford3, Juan Valle4, Bipasha Chakrabarty5.   

Abstract

Goblet cell carcinoids (GCCs) of the appendix are rare tumors, characterized by a carcinoid-like organoid growth pattern. Despite the term carcinoid, neuroendocrine features are inconspicuous, and its behavior is distinct from carcinoid. Its high-grade counterpart is designated as adenocarcinoma ex GCC. We conducted a retrospective study of 105 tumors to find prognostic values of a variety of clinicopathologic features. The tumors were subclassified as low grade, equivalent to classic type, and high grade, defined as loss of organoid pattern, and a proportion (%) of low and high grades were documented in each tumor. Correlations between survival and various clinicopathologic parameters were investigated. One-third were pure low grade, while the remainder contained variable high-grade component ranging from 5% to 95%. Neuroendocrine cell component ranged from 0% to 90% (median, 5), while mucus cell component ranged from 5% to 100% (median, 70). By univariate analysis, size, stage, high-grade component, nuclear grade, surgery, and chemotherapy correlated with cancer-related survival (CSS), and by multivariate analysis, stage (P=.001), high-grade component (P=.008), and tumor size (P=.005) correlated with CSS. There was significant difference in CSS when the cases were grouped by high-grade component: <40%, 40% to 90%, and ≤90% (P<.001). Our results indicate that staging and proportion of high-grade histology may provide important prognostic information. Neuroendocrine component was insignificant in both low- and high-grade areas. In light of our findings, this tumor type is best regarded as a variant of adenocarcinoma, and the term crypt cell adenocarcinoma more appropriately reflects the nature and origin of this tumor group.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amphophilic; Appendix; Crypt cell adenocarcinoma; Goblet cell carcinoid; Mucinous; Neuroendocrine

Mesh:

Substances:

Year:  2017        PMID: 28823572     DOI: 10.1016/j.humpath.2017.08.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Perianal Goblet Cell Carcinoid With Pagetoid Spread.

Authors:  Dianne Grunes; Michelle Kang Kim; David B Chessin; Rona D Yaeger; Stephen C Ward
Journal:  Int J Surg Pathol       Date:  2019-05-13       Impact factor: 1.271

Review 2.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  Appendiceal goblet cell carcinomas have poor survival despite completion surgery.

Authors:  Edward Alabraba; David Mark Pritchard; Rebecca Griffin; Rafael Diaz-Nieto; Melissa Banks; Daniel James Cuthbertson; Stephen Fenwick
Journal:  Endocrine       Date:  2021-04-23       Impact factor: 3.633

4.  Cerebral Metastases in Appendiceal Cancer: Comprehensive Review and Report of Rare Medullary Carcinoma Histology.

Authors:  Charles Mackel; Harry Rosenberg; Hemant Varma; Rafael Vega; Martina Stippler
Journal:  Brain Tumor Res Treat       Date:  2022-07

5.  Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry.

Authors:  Kieran Palmer; Scott Weerasuriya; Kandiah Chandrakumaran; Brian Rous; Benjamin E White; Sangeeta Paisey; Rajaventhan Srirajaskanthan; John K Ramage
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

6.  Goblet cell carcinoid of the appendix: Two case reports and a review of the literature.

Authors:  Alejandro Livoff; Noam Asna; Enrique Gallego-Colon; Aner Zeev Daum; Tattiana Harkovsky; Moshe Schaffer
Journal:  Mol Clin Oncol       Date:  2019-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.